MAPT and Alzheimer disease: The three antibody fragments produced this way were able to detect tau oligomers in the brain tissue extracts of 3xTG-AD and Tau406+/TauKO (expressing mutant human tau (4R) in a mouse tau knock-out background) mice as well as in the human AD brain.